. 2018 Oct 10;8:15080. doi: 10.1038/s41598-018-33310-4

Table 4.

Spearman Rho correlations between plasma miRNA-323b-5p level and CLI risk factors in T2DM patients.

Variable		miRNA-323b-5p
T2D Duration	rho	0.251
T2D Duration	p	0.059
Hypertension	rho	0.201
Hypertension	p	0.131
Smoking	rho	0.275
Smoking	p	0.037
FPG	rho	0.285
FPG	p	0.030
HbA1c	rho	0.335
HbA1c	P	0.010
TC	rho	−0.255
TC	p	0.053
Cr	rho	0.055
Cr	p	0.682
Statin use	rho	−0.205
Statin use	p	0.124
Antihypertensive treatment	rho	−0.079
Antihypertensive treatment	p	0.555

CI, confidence interval; FPG, fasting plasma glucose; HbA1c, glycosylated hemoglobin; TC, total cholesterol; Cr, serum creatinine. *Adjusted for T2D Duration, hypertension, smoking, FPG, HbA1c, TC, Cr. All study subjects were included in the analysis. Significant values are marked in italic.